FDA has approved a new animal drug application concerning AquAdvantage Salmon, a genetically engineered Atlantic salmon. Documents related to this approval are available below.
AquAdvantage Salmon Approval Letter and Appendix AquAdvantage Salmon FOI Summary(PDF - 3.7MB) AquAdvantage Salmon Environmental Assessment(PDF - 9.6MB) AquAdvantage Salmon FONSI(PDF - 252KB) AquAdvantage Salmon - Response to Public Comments on the Environmental Assessment AquAdvantage Salmon - FDA Response to Public Comments to the Veterinary Medicine Advisory Committee AquAdvantage Salmon - FDA Analysis of Potential Impacts on the Environments of the Global Commons and of Foreign Nations not Participating in the Action for NADA # 141-454 Earth Justice Petition Regarding Pending Application of AquaBounty Technologies for Approval of Genetically-Engineered Salmon
- Food and Water Watch Petition that the FDA deem AquaBounty Technologies' genetically engineered AquAdvantage Salmon an unsafe food additive
- Notice of Draft Environmental Assessment and Preliminary Finding of No Significant Impact Concerning a Genetically Engineered Atlantic Salmon
AquAdvantage Salmon Draft Environmental Assessment(PDF - 3.8MB) [ARCHIVED] AquAdvantage Salmon Preliminary Finding of No Significant Impact(PDF - 62KB) [ARCHIVED]